Juniper Pharmaceuticals Inc logo

JNP - Juniper Pharmaceuticals Inc News Story

$11.5 0.0  0.0%

Last Trade - 13/08/18

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £39.5m
Position in Universe th / 6846

BRIEF-Krensavage Asset Management urges Juniper Pharmaceuticals to consider sale

Wed 12th April, 2017 12:04pm
April 12 (Reuters) - Juniper Pharmaceuticals Inc  JNP.O  
    * Krensavage Asset Management urges Juniper Pharmaceuticals 
to consider sale of company 
    * Krensavage Asset Management LLC, a 2.2% shareholder of 
Juniper Pharmaceuticals, publishes open letter 
 
Source text for Eikon:  ID:nPn8HRsjWa  
Further company coverage:  JNP.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.